| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00125-014-3186-Z |
| P698 | PubMed publication ID | 24633676 |
| P50 | author | Marit E. Jørgensen | Q38219648 |
| P2093 | author name string | Søren Friis | |
| Bendix Carstensen | |||
| Kristina Ranc | |||
| P2860 | cites work | Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis | Q34976375 |
| Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival | Q35688186 | ||
| Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009 | Q36194042 | ||
| Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer | Q36303910 | ||
| Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis | Q36710824 | ||
| Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence | Q38000088 | ||
| Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer | Q38000089 | ||
| Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis | Q38080666 | ||
| The Danish National Diabetes Register: trends in incidence, prevalence and mortality | Q38454178 | ||
| Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. | Q43091072 | ||
| Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort | Q44281903 | ||
| Age-period-cohort models for the Lexis diagram | Q45047659 | ||
| Cancer occurrence in Danish diabetic patients: duration and insulin effects | Q45387850 | ||
| The Danish Cancer Registry | Q45848855 | ||
| Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin | Q46917157 | ||
| The Danish Cancer Registry--history, content, quality and use. | Q50174956 | ||
| The Danish Civil Registration System. | Q50554185 | ||
| The Danish National Patient Register. | Q50554196 | ||
| Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. | Q54570063 | ||
| Lexis: AnRClass for Epidemiological Studies with Long-Term Follow-Up | Q58475730 | ||
| The National Diabetes Register | Q63753903 | ||
| Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations | Q84032523 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 927-934 | |
| P577 | publication date | 2014-03-15 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment | |
| P478 | volume | 57 |
| Q41266143 | Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey |
| Q38869694 | Co-Managing Patients with Type 1 Diabetes and Cancer |
| Q35800392 | Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. |
| Q38226775 | Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature |
| Q47209760 | Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication. |
| Q38999285 | Diabetes and kidney cancer outcomes: a propensity score analysis |
| Q89678121 | Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus |
| Q38728033 | Diabetology and oncology meet in a network model: union is strength |
| Q38388443 | Drug-subphenotype interactions for cancer in type 2 diabetes mellitus |
| Q36182971 | Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study |
| Q64117465 | Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy |
| Q87926734 | Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus |
| Q64240627 | Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients |
| Q47129584 | Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives. |
| Q38604430 | In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome. |
| Q50087129 | Influence of specific comorbidities on survival after early-stage breast cancer |
| Q39063925 | Insights into the relationships between diabetes, prediabetes, and cancer |
| Q28396199 | Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation |
| Q88009240 | Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs |
| Q57734592 | Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Cur |
| Q57212826 | Optimal Starting Age for Colorectal Cancer Screening in an Era of Increased Metabolic Unhealthiness: A Nationwide Korean Cross-Sectional Study |
| Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
| Q47238502 | Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia |
| Q41518671 | Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia |
| Q34032658 | Real life cancer comorbidity in Greek patients with diabetes mellitus followed up at a single diabetes center: an unappreciated new diabetes complication |
| Q37483954 | Relationship between level of HbA1C and breast cancer |
| Q38214338 | Sex and gender influences on pharmacological response: an overview |
| Q38243241 | The epidemiology of diabetes and cancer |
| Q64915919 | The impact of cancer on diabetes outcomes. |
| Q50020860 | Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort |
Search more.